Thorunn Rafnar

Title: The Innovative Contributions of Thorunn Rafnar

Introduction

Thorunn Rafnar is a prominent inventor based in Baltimore, MD (US), known for her significant contributions to the field of allergy treatment. With a total of four patents to her name, she has made remarkable strides in developing methods to address sensitivity to protein allergens, particularly those associated with ragweed pollen.

Latest Patents

Rafnar's latest patents focus on innovative methods for treating sensitivity to protein allergens using peptides. One of her notable patents describes methods that include a T cell epitope recognized by a T cell receptor specific for the protein allergen, specifically Antigen E or I of ragweed pollen. This work has revealed that these antigens belong to a family of proteins. Additionally, her patents disclose cDNAs encoding the major human allergen of ragweed and peptides derived from it, along with antibodies against these peptides. These advancements provide new avenues for treating individuals sensitive to ragweed.

Career Highlights

Throughout her career, Thorunn Rafnar has worked with esteemed organizations such as Immunologic Pharmaceutical Corporation and the University of North Carolina at Chapel Hill. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Rafnar has collaborated with notable colleagues, including Bruce L. Rogers and David G. Klapper. These partnerships have further enhanced her research and innovation in allergy treatment.

Conclusion

Thorunn Rafnar's work exemplifies the impact of innovative thinking in addressing health challenges related to allergies. Her patents and collaborations highlight her dedication to improving the lives of individuals affected by protein sensitivities.